As Dr. Veith and the meeting that bears his name join forces with the Cleveland Clinic, he discusses the newly formed ISVS, board certification, and the evolution of vascular “surgery.”
By Frank J. Veith, MD
New technologies show potential to reduce amputation rates for atherosclerotic lower-limb ischemia.
By Prakash Makam, MD
Is this recently FDA-cleared technology applicable to the acute exclusion and follow-up of thoracic aortic aneurysms?
By Ross Milner, MD
Evolved from the Talent, this new device design improves trackability and enables a lower force of deployment.
By Matt Thompson, MD, and Rob Morgan, MD
Should endovascular repair be considered the standard of treatment?
By Peter H. Lin, MD, and Alan B. Lumsden, MD
Combination surgical and EVAR approaches for treating arch and descending thoracic aneurysms.
By Roy K. Greenberg, MD, and Lars Svensson, MD, PhD
Tips and tricks to ensure accurate device placement, patient safety, and durable outcomes.
By Takao Ohki, MD, PhD
Experiences and insights on treating arch and thoracoabdominal aortic aneurysms with branched grafts.
By Timothy A. M. Chuter, md; Roy K. Greenberg, MD; and David Hartley
Repair of descending thoracic aneurysm with the TAG device has shown improved short- and midterm results compared to open repair.
By Jae-Sung Cho, MD, and Michel Makaroun, MD
The FDA is focused on improving the conduct and quality of clinical trials, and here is how you can help.
By Robert P. Fiorentino, MD, MPH, and Takahiro Uchida, MD, MSc
By Takao Ohki, MD, PhD, Chief Medical Editor
An overview of endovascular options for patients with blunt traumatic rupture of the thoracic aorta.
By Philippe Amabile, MD, and Philippe Piquet, MD
VESSEL UPDATE: INFRAPOPLITEAL
New data show effectiveness in the treatment of critical limb ischemia caused by infrapopliteal lesions.